ArticleClinical and translational medicine2025
Responsiveness of different MET tumour alterations to type I and type II MET inhibitors.
Yonina R Murciano-Goroff et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it